Literature DB >> 14965149

Patient counseling provided in community pharmacies: effects of state regulation, pharmacist age, and busyness.

Bonnie L Svarstad1, Dara C Bultman, Jeanine K Mount.   

Abstract

OBJECTIVE: To describe the nature and extent of patient counseling in community pharmacies and determine whether current counseling practices are influenced by pharmacist and pharmacy characteristics and variations in state regulation of patient counseling.
DESIGN: Observational, cross-sectional study.
SETTING: 306 community pharmacies in eight states. PARTICIPANTS: Trained shoppers (acting as patients).
INTERVENTIONS: Three new prescriptions were presented in each pharmacy, and regression techniques were used to analyze the effects of pharmacist age, pharmacy type, and busyness; whether written information was provided; and "intensity" of a state's patient counseling regulation as measured by its scope, stringency, and duration. MAIN OUTCOME MEASURES: Whether any or all of these events occurred: pharmacist talked with shopper, oral drug information was given, oral risk information was given, and/or questions were asked to assess shopper understanding; number of informational items mentioned (range 0-7) was also recorded.
RESULTS: About 63% of the shoppers were given oral drug information (mean = 2.3 items). Shoppers with a younger responsible pharmacist were more likely than other shoppers to receive risk information, a higher number of informational items, and assessment of understanding. While pharmacy type was unrelated to counseling, busyness reduced the odds of any pharmacist talk, oral information-giving, and assessment of understanding. Counseling practices varied significantly according to the intensity of a state's counseling regulation, with frequency of any information provision climbing from 40% to 94% as states' counseling regulations increased in intensity. More intensive regulations also increased the likelihood of any pharmacist talk, any provision of risk information, any assessment of shopper understanding, and amount of oral information given.
CONCLUSION: Counseling varied significantly according to intensity of state regulation, pharmacy busyness, and age of responsible pharmacist. These results present important challenges to state boards of pharmacy, pharmacy associations, managers, and individual practitioners who are in a position to improve this important element of patient care.

Entities:  

Mesh:

Year:  2004        PMID: 14965149     DOI: 10.1331/154434504322713192

Source DB:  PubMed          Journal:  J Am Pharm Assoc (2003)        ISSN: 1086-5802


  40 in total

1.  A self-reported work-sampling study in community pharmacy practice: a 2009 update.

Authors:  Laura McCann; Carmel M Hughes; Colin G Adair
Journal:  Pharm World Sci       Date:  2010-06-18

2.  New prescriptions: how well do patients remember important information?

Authors:  Derjung M Tarn; Susan A Flocke
Journal:  Fam Med       Date:  2011-04       Impact factor: 1.756

3.  How do Australian metropolitan and rural pharmacists counsel consumers with prescriptions?

Authors:  Hanni Prihhastuti Puspitasari; Parisa Aslani; Ines Krass
Journal:  Pharm World Sci       Date:  2009-03-04

4.  Evaluating the Impact of an Anti-stigma Intervention on Pharmacy Students' Willingness to Counsel People Living with Mental Illness.

Authors:  Benita A Bamgbade; Jamie C Barner; Kentya H Ford
Journal:  Community Ment Health J       Date:  2016-12-15

5.  Individual- and neighborhood-level factors associated with nonprescription counseling in pharmacies participating in the New York State Expanded Syringe Access Program.

Authors:  Alexis V Rivera; Shannon Blaney; Natalie D Crawford; Kellee White; Rachel J Stern; Silvia Amesty; Crystal Fuller
Journal:  J Am Pharm Assoc (2003)       Date:  2010 Sep-Oct

6.  Unexpected effects of unintended consequences: EMR prescription discrepancies and hemorrhage in patients on warfarin.

Authors:  Alexander Turchin; Maria Shubina; Saveli Goldberg
Journal:  AMIA Annu Symp Proc       Date:  2011-10-22

7.  Provision of smoking cessation services in Australian community pharmacies: a simulated patient study.

Authors:  Maya Saba; Jessica Diep; Renee Bittoun; Bandana Saini
Journal:  Int J Clin Pharm       Date:  2014-04-10

8.  Which providers should communicate which critical information about a new medication? Patient, pharmacist, and physician perspectives.

Authors:  Derjung M Tarn; Debora A Paterniti; Bradley R Williams; Camille S Cipri; Neil S Wenger
Journal:  J Am Geriatr Soc       Date:  2009-01-17       Impact factor: 5.562

9.  Intervention to enhance communication about newly prescribed medications.

Authors:  Derjung M Tarn; Debora A Paterniti; Deborah K Orosz; Chi-Hong Tseng; Neil S Wenger
Journal:  Ann Fam Med       Date:  2013 Jan-Feb       Impact factor: 5.166

10.  Impact of interpreters on the receipt of new prescription medication information among Spanish-speaking Latinos.

Authors:  Gerardo Moreno; Derjung M Tarn; Leo S Morales
Journal:  Med Care       Date:  2009-12       Impact factor: 2.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.